Publications

5491 Results

The effect of radiation modality on outcomes of patients with resected extrahepatic cholangiocarcinoma or gallbladder carcinoma treated with adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine: a secondary analysis of SWOG S0809

Authors
D Horowitz;M Duong;S Gholami;K Guthrie;F Rocha;E Ben-Josef;C Blanke;A El-Khoueiry;P Philip;S Ahmad;L Kachnic
Journal / Conference
American Society for Radiation Oncology (ASTRO) Annual Meeting (October 24-27, 2021), poster
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
S0809

A 584bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion, and confers risk of pancreatic cancer

Authors
A Jermusyk;J Zhong;K Connelly;N Gordon;S Perera;E Abdolailzadeh;T Zhang;A O'Brien;J Hoskins;I Collins;D Eiser;C Yuan;PGoodman PanScan Corsortium;PanCfour Consortium;H Risch;E Jacobs;D Li;M Du;R Stolzenberg-Solomon;A Klein;J Smith;B Wolpin;S Chanock;J Shi;G Petersen;C Westlake;L Amundadottir
Journal / Conference
American Journal of Human Genetics Oct 7;108(10):1852-1865. doi: 10.1016/j.ajhg.2021.09.002. Epub 2021 Sep 23.
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID34559995
PMC
PMC8546220
Study Number(s)
S0000

Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma

Authors
K Grossmann;M Othus;S Patel;A Tarhini;V Sondak;M Knopp;T Petrella;T-G Truong;N Khushalani;J Cohen;E Buchbinder;K Kendra;P Funchain;K Lewis;R Conry;B Chmielowski;R Kudchadkar;D Johnson;H Li;J Moon;J Eroglu;B Gastman;M Kovacsovics;K Gunturu;S Ebbinghaus;S Ahsan;N Ibrahim;E Sharon;L Korde;J Kirkwood;A Ribas
Journal / Conference
Cancer Discovery Mar 1;12(3):644-653
Year
2021
Research Committee(s)
Melanoma
PMID
PMID34764195 PMC8904282
PMC
PMC8904282
Study Number(s)
S1404

Trial-in-Progress: Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma (NCT#03269669): SWOG S1608

Authors
P Barr;H Li;B Link;C Flowers;WR Burack;H Schoder;M LeBlanc;O Weigert;A Herrera;D Weinstock;J Leonard;B Kahl;S Smith;JW Friedberg
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #2425
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1608

New prognostic score incorporating MTV predicts treatment failure in advanced Hodgkin Lymphoma

Authors
S Barrington;A Kirkwood;L Pike;C Guezennec;H Li;M Leblanc;D Poon;M Knopp;L Clifton-Hadley;C Laubach;H Schoder;JW Friedberg;P Johnson
Journal / Conference
International Conference on Malignant Lymphoma 2021 (tentative June 2021), oral
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Cognitive Function And Quality Of Life In Long Term Survivors Of RTOG 9402

Authors
L Donavan;M Won;J Cairncross;F Iwamoto;J Buckner;K Fink;J-P Bahary;A Hartford;L Souhami;T Nguyen;T Cescon;M Mishra;I Barani;A Pu;W Roa;J Huang;M Polley;M Mehta
Journal / Conference
Society for Neuroncology (SNO) Annual Meeting (November 18-21, 2021, Boston), oral
Year
2021
Research Committee(s)
Brain
Study Number(s)
SWOG-9402

Treatment-specific gene regulatory pathways in colorectal cancer patients

Authors
A Yazdani;H-J Lenz;X Qu;M Bertagnolli;A Venook;F Innocenti
Journal / Conference
American Society of Human Genetics (ASHG) Annual Meeting (October 18-22), poster, PrgmNr 2776
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Distant-Disease Free Interval in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): SWOG S1007 (RxPONDER)

Authors
K Kalinsky;W Barlow;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;M Martin;C Kelly;M Ruiz Borrego;M Gil-Gil;C Arce-Salinas;E Brain;E Lee;J-Y Pierga;B Bermejo;M Ramos Vazquez;K Jung;J-M Ferrero;A Schott;S Shak;P Sharma;D Lew;J Miao;D Tripathy;L Pusztai;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), oral slide presentation, #GS2-07
Year
2021
Research Committee(s)
Breast
Study Number(s)
S1007

Evaluation of the predicted sensitivity to endocrine therapy (SET2,3 index) and the 21-gene Recurrence Score in node-positive postmenopausal breast cancer: results from an analysis in the SWOG S8814 trial

Authors
C Speers;WF Symmans;W Barlow;A Trevarton;S The;L Du;J Rae;S Shak;R Baehner;P Sharma;L Pusztai;G Hortobagyi;D Hayes;K Albain;A Godwin;A Thompson
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), spotlight poster discussion, #PD9-06
Year
2021
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

SWOG S1931 (PROBE trial): Phase III randomized trial of Immune checkpoint inhibitor (ICI) combination regimen with or without Cytoreductive Nephrectomy (CN) in Advanced Renal Cancer

Authors
U Vaishampayan;C Tangen;A Tripathi;B Shuch;S Pal;P Barata;A Tan;P Zuckerman;E Mayerson;P Lara;N Agarwal;N Vogelzang;I Thompson;H Kim
Journal / Conference
Society of Urologic Oncology (Dec 1-3, 2021, Orlando, FL), poster
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
S1931